ArticleBMJ open2023

Economic evaluation of serplulimab plus chemotherapy as the first-line treatment of oesophageal squamous cell carcinoma in China.

Fang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.